Convexity Scientific said yesterday that it closed a Series B financing round worth nearly $4 million ahead of the launch of its Flyp nebulizer.
Fairfield, Conn.-based Convexity’s funding was led by HighCape Capital with participation from Connecticut Innovations, Benslie International and Stonehenge Capital, according to a news release.
The company said the funding is earmarked for the commercial growth of the Flyp nebulizer and adjacent innovations. The Flyp device is a pocket-portable nebulizer designed to simplify management of chronic respiratory conditions like asthma and chronic obstructive pulmonary disease by delivering medication deep into the lungs through fast treatments.
Get the full story at our sister site, Drug Delivery Business News.
